1 Market Overview
1.1 Opioids Product Introduction
1.2 Global Opioids Market Size Forecast
1.2.1 Global Opioids Sales Value (2019-2034)
1.2.2 Global Opioids Sales Volume (2019-2034)
1.2.3 Global Opioids Sales Price (2019-2034)
1.3 Opioids Market Trends & Drivers
1.3.1 Opioids Industry Trends
1.3.2 Opioids Market Drivers & Opportunity
1.3.3 Opioids Market Challenges
1.3.4 Opioids Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Opioids Players Revenue Ranking (2024)
2.2 Global Opioids Revenue by Company (2019-2025)
2.3 Global Opioids Players Sales Volume Ranking (2024)
2.4 Global Opioids Sales Volume by Company Players (2019-2025)
2.5 Global Opioids Average Price by Company (2019-2025)
2.6 Key Manufacturers Opioids Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Opioids Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Opioids
2.9 Opioids Market Competitive Analysis
2.9.1 Opioids Market Concentration Rate (2019-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Opioids Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioids as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oxycodone
3.1.2 Hydromorphone
3.1.3 Codeine
3.1.4 Fentanyl
3.1.5 Other
3.2 Global Opioids Sales Value by Type
3.2.1 Global Opioids Sales Value by Type (2019 VS 2024 VS 2034)
3.2.2 Global Opioids Sales Value, by Type (2019-2034)
3.2.3 Global Opioids Sales Value, by Type (%) (2019-2034)
3.3 Global Opioids Sales Volume by Type
3.3.1 Global Opioids Sales Volume by Type (2019 VS 2024 VS 2034)
3.3.2 Global Opioids Sales Volume, by Type (2019-2034)
3.3.3 Global Opioids Sales Volume, by Type (%) (2019-2034)
3.4 Global Opioids Average Price by Type (2019-2034)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pain Relief
4.1.2 Anesthesia
4.1.3 Cough Suppression
4.1.4 Diarrhea Suppression
4.1.5 Deaddiction
4.1.6 Others
4.2 Global Opioids Sales Value by Application
4.2.1 Global Opioids Sales Value by Application (2019 VS 2024 VS 2034)
4.2.2 Global Opioids Sales Value, by Application (2019-2034)
4.2.3 Global Opioids Sales Value, by Application (%) (2019-2034)
4.3 Global Opioids Sales Volume by Application
4.3.1 Global Opioids Sales Volume by Application (2019 VS 2024 VS 2034)
4.3.2 Global Opioids Sales Volume, by Application (2019-2034)
4.3.3 Global Opioids Sales Volume, by Application (%) (2019-2034)
4.4 Global Opioids Average Price by Application (2019-2034)
5 Segmentation by Region
5.1 Global Opioids Sales Value by Region
5.1.1 Global Opioids Sales Value by Region: 2019 VS 2024 VS 2034
5.1.2 Global Opioids Sales Value by Region (2019-2025)
5.1.3 Global Opioids Sales Value by Region (2025-2034)
5.1.4 Global Opioids Sales Value by Region (%), (2019-2034)
5.2 Global Opioids Sales Volume by Region
5.2.1 Global Opioids Sales Volume by Region: 2019 VS 2024 VS 2034
5.2.2 Global Opioids Sales Volume by Region (2019-2025)
5.2.3 Global Opioids Sales Volume by Region (2025-2034)
5.2.4 Global Opioids Sales Volume by Region (%), (2019-2034)
5.3 Global Opioids Average Price by Region (2019-2034)
5.4 North America
5.4.1 North America Opioids Sales Value, 2019-2034
5.4.2 North America Opioids Sales Value by Country (%), 2024 VS 2034
5.5 Europe
5.5.1 Europe Opioids Sales Value, 2019-2034
5.5.2 Europe Opioids Sales Value by Country (%), 2024 VS 2034
5.6 Asia Pacific
5.6.1 Asia Pacific Opioids Sales Value, 2019-2034
5.6.2 Asia Pacific Opioids Sales Value by Country (%), 2024 VS 2034
5.7 South America
5.7.1 South America Opioids Sales Value, 2019-2034
5.7.2 South America Opioids Sales Value by Country (%), 2024 VS 2034
5.8 Middle East & Africa
5.8.1 Middle East & Africa Opioids Sales Value, 2019-2034
5.8.2 Middle East & Africa Opioids Sales Value by Country (%), 2024 VS 2034
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Opioids Sales Value Growth Trends, 2019 VS 2024 VS 2034
6.2 Key Countries/Regions Opioids Sales Value
6.2.1 Key Countries/Regions Opioids Sales Value, 2019-2034
6.2.2 Key Countries/Regions Opioids Sales Volume, 2019-2034
6.3 United States
6.3.1 United States Opioids Sales Value, 2019-2034
6.3.2 United States Opioids Sales Value by Type (%), 2024 VS 2034
6.3.3 United States Opioids Sales Value by Application, 2024 VS 2034
6.4 Europe
6.4.1 Europe Opioids Sales Value, 2019-2034
6.4.2 Europe Opioids Sales Value by Type (%), 2024 VS 2034
6.4.3 Europe Opioids Sales Value by Application, 2024 VS 2034
6.5 China
6.5.1 China Opioids Sales Value, 2019-2034
6.5.2 China Opioids Sales Value by Type (%), 2024 VS 2034
6.5.3 China Opioids Sales Value by Application, 2024 VS 2034
6.6 Japan
6.6.1 Japan Opioids Sales Value, 2019-2034
6.6.2 Japan Opioids Sales Value by Type (%), 2024 VS 2034
6.6.3 Japan Opioids Sales Value by Application, 2024 VS 2034
6.7 South Korea
6.7.1 South Korea Opioids Sales Value, 2019-2034
6.7.2 South Korea Opioids Sales Value by Type (%), 2024 VS 2034
6.7.3 South Korea Opioids Sales Value by Application, 2024 VS 2034
6.8 Southeast Asia
6.8.1 Southeast Asia Opioids Sales Value, 2019-2034
6.8.2 Southeast Asia Opioids Sales Value by Type (%), 2024 VS 2034
6.8.3 Southeast Asia Opioids Sales Value by Application, 2024 VS 2034
6.9 India
6.9.1 India Opioids Sales Value, 2019-2034
6.9.2 India Opioids Sales Value by Type (%), 2024 VS 2034
6.9.3 India Opioids Sales Value by Application, 2024 VS 2034
7 Company Profiles
7.1 Teva
7.1.1 Teva Company Information
7.1.2 Teva Introduction and Business Overview
7.1.3 Teva Opioids Sales, Revenue and Gross Margin (2019-2025)
7.1.4 Teva Opioids Product Offerings
7.1.5 Teva Recent Development
7.2 Purdue Pharma
7.2.1 Purdue Pharma Company Information
7.2.2 Purdue Pharma Introduction and Business Overview
7.2.3 Purdue Pharma Opioids Sales, Revenue and Gross Margin (2019-2025)
7.2.4 Purdue Pharma Opioids Product Offerings
7.2.5 Purdue Pharma Recent Development
7.3 Mallinckrodt
7.3.1 Mallinckrodt Company Information
7.3.2 Mallinckrodt Introduction and Business Overview
7.3.3 Mallinckrodt Opioids Sales, Revenue and Gross Margin (2019-2025)
7.3.4 Mallinckrodt Opioids Product Offerings
7.3.5 Mallinckrodt Recent Development
7.4 Amneal Pharma
7.4.1 Amneal Pharma Company Information
7.4.2 Amneal Pharma Introduction and Business Overview
7.4.3 Amneal Pharma Opioids Sales, Revenue and Gross Margin (2019-2025)
7.4.4 Amneal Pharma Opioids Product Offerings
7.4.5 Amneal Pharma Recent Development
7.5 Collegium
7.5.1 Collegium Company Information
7.5.2 Collegium Introduction and Business Overview
7.5.3 Collegium Opioids Sales, Revenue and Gross Margin (2019-2025)
7.5.4 Collegium Opioids Product Offerings
7.5.5 Collegium Recent Development
7.6 J&J
7.6.1 J&J Company Information
7.6.2 J&J Introduction and Business Overview
7.6.3 J&J Opioids Sales, Revenue and Gross Margin (2019-2025)
7.6.4 J&J Opioids Product Offerings
7.6.5 J&J Recent Development
7.7 Endo
7.7.1 Endo Company Information
7.7.2 Endo Introduction and Business Overview
7.7.3 Endo Opioids Sales, Revenue and Gross Margin (2019-2025)
7.7.4 Endo Opioids Product Offerings
7.7.5 Endo Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Opioids Sales, Revenue and Gross Margin (2019-2025)
7.8.4 Pfizer Opioids Product Offerings
7.8.5 Pfizer Recent Development
7.9 INSYS
7.9.1 INSYS Company Information
7.9.2 INSYS Introduction and Business Overview
7.9.3 INSYS Opioids Sales, Revenue and Gross Margin (2019-2025)
7.9.4 INSYS Opioids Product Offerings
7.9.5 INSYS Recent Development
7.10 Mylan
7.10.1 Mylan Company Information
7.10.2 Mylan Introduction and Business Overview
7.10.3 Mylan Opioids Sales, Revenue and Gross Margin (2019-2025)
7.10.4 Mylan Opioids Product Offerings
7.10.5 Mylan Recent Development
7.11 Hikma
7.11.1 Hikma Company Information
7.11.2 Hikma Introduction and Business Overview
7.11.3 Hikma Opioids Sales, Revenue and Gross Margin (2019-2025)
7.11.4 Hikma Opioids Product Offerings
7.11.5 Hikma Recent Development
7.12 Egalet
7.12.1 Egalet Company Information
7.12.2 Egalet Introduction and Business Overview
7.12.3 Egalet Opioids Sales, Revenue and Gross Margin (2019-2025)
7.12.4 Egalet Opioids Product Offerings
7.12.5 Egalet Recent Development
8 Industry Chain Analysis
8.1 Opioids Industrial Chain
8.2 Opioids Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Opioids Sales Model
8.5.2 Sales Channel
8.5.3 Opioids Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
